MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Patterns and determinants of healthcare utilization among people with Parkinson’s disease: A population based analysis in Ontario, Canada

    E. Crighton, A. Ouédraogo, M. Sawada, T. Mestre (Ottawa, Canada)

    Objective: To identify spatial patterns of healthcare utilization among people with Parkinson’s disease (PwP) and examine factors associated with individuals’ observed access-to-care in Ontario. Background:…
  • MDS Virtual Congress 2021

    The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US

    D. Oleske, S. Talapala, P. Kukreja, M. Facheris, R. Dorsey, S. Dey, A. Isherwood (North Chicago, USA)

    Objective: Characterize the risk of seven acute medical events in persons with advanced Parkinson’s disease (PD) using real world data before and within 12 months…
  • MDS Virtual Congress 2021

    Neuro-Behavioral Therapy for Functional Movement Disorders: Conceptual Framework and Future Directions

    J. Mack, WC. Lafrance, JR. (Portland, USA)

    Objective: To explore modifications to an established, evidence-based psychological treatment for patients with psychogenic non-epileptic seizures (PNES) with the goal of studying a manualized psychotherapy…
  • MDS Virtual Congress 2021

    Be aware of pitfalls: Bioinformatic analysis of Cas9-targeted Nanopore sequencing of the RFC1 repeat in CANVAS

    I. Wohlers, H. Pott, S. Schaake, J. Trinh, H. Busch, K. Lohmann (Lübeck, Germany)

    Objective: To determine the full sequence and length of the pentanucleotide repeat in the RFC1 gene by Cas9-targeted Nanopore sequencing in patients with cerebellar ataxia…
  • MDS Virtual Congress 2021

    Genetic features and long-term outcome of Korean patients with Huntington’s disease.

    YS. Hwang, SY. Jo, SH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the genetic characteristics and long-term outcome of Korean patients with Huntington’s disease. Background: Huntington’s disease is an autosomal dominant neurodegenerative disease, which…
  • MDS Virtual Congress 2021

    Burden of illness among US Medicare beneficiaries with late-onset Huntington’s disease

    J. Ta, S. Reiss Reddy, E. Chang, A. Exuzides, R. Gandhy, G. Yohrling (South San Francisco, USA)

    Objective: Examine healthcare resource utilization (HRU) and costs among US Medicare beneficiaries with late-onset Huntington’s disease (LoHD). Background: Huntington’s disease (HD) is a genetic, neurodegenerative…
  • MDS Virtual Congress 2021

    The Burst Duration in Cortical Myoclonus Patients, What is the Cut-Off?

    S. vd Veen, A. vd Stouwe, J. Elting, M. Tijssen (Groningen, Netherlands)

    Objective: The aim of this study is to identify a cut-off value for the burst duration of cortical myoclonus in a large cohort of myoclonus…
  • MDS Virtual Congress 2021

    Efficacy of Incobotulinumtoxin/A Treatment for Children/Adolescents with Sialorrhea associated with Neurological Disorders

    S. Berweck, H. Kim, M. Banach, A. Hanschmann, M. Althaus, M. Bonikowski (Vogtareuth, Germany)

    Objective: The SIPEXI (Sialorrhea Pediatric Xeomin Investigation) study investigated efficacy and safety of intraglandular incobotulinumtoxinA (incoBoNT/A) injections in children/adolescents with sialorrhea associated with neurological disorders…
  • MDS Virtual Congress 2021

    Stiff-person syndrome – a 15-year review at a tertiary hospital

    R. Rodrigues, L. Sousa, R. Samões, G. Cação, J. Chaves, M. Cardoso, J. Barros, E. Santos, J. Damásio (Santa Maria Feira, Portugal)

    Objective: Clinical characterization of stiff-person syndrome (SPS). Background: SPS typically presents with progressive symmetric axial and proximal limb rigidity, and episodic painful spasms triggered by…
  • MDS Virtual Congress 2021

    Spectrum of Movement Disorders among Children with Subacute Sclerosing Panencephalitis (SSPE): A Cross-sectional Study

    D. Garg, V. Kakkar, D. Kapoor, S. Sharma, S. Mukherjee, H. Pemde (New Delhi, India)

    Objective: We aimed to assess spectrum of movement disorders associated with pediatric SSPE. Background: Subacute sclerosing panencephalitis (SSPE) is a rare neurodegenerative disorder due to…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley